Activity Preview

Live

Vaccines for Opioid Use Disorder: Focusing on the Fentanyl Epidemic

Activity Type:

  • On Demand


Release Date: 5/28/2019

Expiration Date: 5/28/2022

  • AMA PRA Category 1: 1
  • Participation: 1

Access Activity

Overview

Fentanyl has been the leading cause of opioid overdoses during the last couple of years, and these overdoses are not prevented by methdone, buprenorphine or naltrexone treatment. However, a vaccine against fentanyl has been able to block fentanyl's analgesic, reinforcing and respiratory effects in animal models. This vaccine is moving forward FDA approval to be tested in humans. This presentation will discuss the mechanism of acting for fentanyl vaccines in preventing overdoses and abuse through the production of anti-fentanyl antibodies.

Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Pricing

  • General Member - Free
  • Resident-Fellow Member - Free
  • Medical Student Member - Free
  • Non-Member - Free

Educational Objectives

  • Identify the extent and greatest geographic concentration of fentanyl overdoses and abuse in the current USA opioid epidemic.
  • Define how and why current treatments with naltrexone, methadone and buprenorphine are ineffective for fentanyl abuse.
  • Identify the mechanism of acting for fentanyl vaccines in preventing overdoses and abuse through the production of anti-fentanyl antibodies.

Target Audience

Physicians who have a waiver to treat opioid use disorder in an office-based setting and other interested clinicians.

Estimated Time to Complete

Estimated Duration: 1 hour
Begin Date: May 28, 2019
End Date: May 28, 2022

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple-choice quiz is provided based on the content. A passing score of 75% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned. 

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Faculty

  • Thomas Kosten, M.D., Director, Division of Alcohol and Addiction Psychiatry, Baylor College of Medicine. Disclosure: Consultant - Alkermes US World Pharma.
  • Fang Yang, M.D., Addiction Psychiatry Fellow, Baylor College of Medicine. Reports no financial relationships with commercial interests.


Program Planners

  • John A. Renner, Jr., M.D., Professor of Psychiatry, Boston University School of Medicine; Director, Addiction Psychiatry Residency Training, Boston University Medical Center and VA Boston Healthcare System. Disclosure: Stockholder: Johnson & Johnson and General Electric.
  • Eunice Maize, American Psychiatric Association. Reports no finanical relationships with commercial interests
  • Rachel Trusty, American Psychiatric Association. Reports no finanical relationships with commercial interests
  • Tristan Gorrindo, M.D., American Psychiatric Association. Reports no finanical relationships with commercial interests

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact pcssmat@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

All materials copyright American Psychiatric Association. ©2019

Access Activity